Biocartis is an innovative molecular diagnostics company committed to revolutionizing molecular testing with its unique proprietary IdyllaTM Platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology. Today, Biocartis offers tests supporting melanoma, colorectal, lung, breast, thyroid, brain and blood cancer. Biocartis is headquartered in Mechelen, Belgium.
Looking for a particular Biocartis employee's phone or email?
The Biocartis annual revenue was $53 million in 2026.
Piet Houwen is the COO of Biocartis.
302 people are employed at Biocartis.
Biocartis is based in Mechelen, Flanders.
The NAICS codes for Biocartis are [6215, 62, 62151, 621].
The SIC codes for Biocartis are [807, 80, 73].